Does ramucirumab deserve a second chance for liver cancer?

Lancet Oncol. 2015 Jul;16(7):751-2. doi: 10.1016/S1470-2045(15)00053-4. Epub 2015 Jun 18.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Carcinoma, Hepatocellular / drug therapy*
  • Female
  • Humans
  • Liver Neoplasms / drug therapy*
  • Male
  • Niacinamide / analogs & derivatives*
  • Phenylurea Compounds / therapeutic use*

Substances

  • Antibodies, Monoclonal
  • Phenylurea Compounds
  • Niacinamide